We have located links that may give you full text access.
The evaluation of anti-osteoclastic activity of the novel calcium hydroxide biodegradable nanoparticles as an intracanal medicament.
Journal of Endodontics 2024 March 5
INTRODUCTION: The aim of this study was to evaluate the anti-osteoclastic activity of calcium hydroxide-loaded poly(lactic-co-glycolic acid) nanoparticles (Ca(OH)2 -loaded PLGA NPs) in comparison to calcium hydroxide nanoparticles (Ca(OH)2 NPs).
METHODS: RAW 264.7 cell lines (third-fifth passage) were cultured and incubated with soluble receptor activator of nuclear factor-κB ligand (RANKL) in triplicates. Subsequently, Ca(OH)2 -loaded PLGA NPs and Ca(OH)2 NPs were added for 7 days to evaluate their effects on RANKL-induced osteoclast differentiation of RAW 264.7 cells by tartrate-resistant acid phosphatase (TRAP) activity. Additionally, a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was conducted to confirm the cytotoxicity of treatments to cells.
RESULTS: TRAP staining showed a significant reduction in osteoclast number when treated with Ca(OH)2 -loaded PLGA NPs than Ca(OH)2 NPs (p<0.01). In comparison to the control, the number of osteoclasts significantly reduced upon treatment with Ca(OH)2 -loaded PLGA NPs (p<0.05) but no significant difference in Ca(OH)2 NPs. Furthermore, osteoclast morphology in both treatment groups exhibited smaller sizes than the control group. Neither Ca(OH)2 -loaded PLGA NPs nor Ca(OH)2 NPs demonstrated cytotoxic effects on RAW264.7 cells.
CONCLUSIONS: Both Ca(OH)2 NPs with and without PLGA have the ability to inhibit osteoclast differentiation. However, Ca(OH)2 -loaded PLGA NPs exhibit greater potential than Ca(OH)2 NPs, making them a promising intracanal medicament for cases of root resorption.
METHODS: RAW 264.7 cell lines (third-fifth passage) were cultured and incubated with soluble receptor activator of nuclear factor-κB ligand (RANKL) in triplicates. Subsequently, Ca(OH)2 -loaded PLGA NPs and Ca(OH)2 NPs were added for 7 days to evaluate their effects on RANKL-induced osteoclast differentiation of RAW 264.7 cells by tartrate-resistant acid phosphatase (TRAP) activity. Additionally, a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was conducted to confirm the cytotoxicity of treatments to cells.
RESULTS: TRAP staining showed a significant reduction in osteoclast number when treated with Ca(OH)2 -loaded PLGA NPs than Ca(OH)2 NPs (p<0.01). In comparison to the control, the number of osteoclasts significantly reduced upon treatment with Ca(OH)2 -loaded PLGA NPs (p<0.05) but no significant difference in Ca(OH)2 NPs. Furthermore, osteoclast morphology in both treatment groups exhibited smaller sizes than the control group. Neither Ca(OH)2 -loaded PLGA NPs nor Ca(OH)2 NPs demonstrated cytotoxic effects on RAW264.7 cells.
CONCLUSIONS: Both Ca(OH)2 NPs with and without PLGA have the ability to inhibit osteoclast differentiation. However, Ca(OH)2 -loaded PLGA NPs exhibit greater potential than Ca(OH)2 NPs, making them a promising intracanal medicament for cases of root resorption.
Full text links
Related Resources
Trending Papers
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app